BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8894072)

  • 1. High-energy phosphate metabolism in the frontal lobes of patients with panic disorder detected by phase-encoded 31P-MRS.
    Shioiri T; Kato T; Murashita J; Hamakawa H; Inubushi T; Takahashi S
    Biol Psychiatry; 1996 Oct; 40(8):785-93. PubMed ID: 8894072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of sleep deprivation: the phosphorus metabolism in the human brain measured by 31P-magnetic resonance spectroscopy.
    Murashita J; Yamada N; Kato T; Tazaki M; Kato N
    Psychiatry Clin Neurosci; 1999 Apr; 53(2):199-201. PubMed ID: 10459688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lateralized abnormality of high energy phosphate metabolism in the frontal lobes of patients with bipolar disorder detected by phase-encoded 31P-MRS.
    Kato T; Shioiri T; Murashita J; Hamakawa H; Takahashi Y; Inubushi T; Takahashi S
    Psychol Med; 1995 May; 25(3):557-66. PubMed ID: 7480436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: a proton magnetic resonance spectroscopy study.
    Ohrmann P; Siegmund A; Suslow T; Pedersen A; Spitzberg K; Kersting A; Rothermundt M; Arolt V; Heindel W; Pfleiderer B
    J Psychiatr Res; 2007 Oct; 41(8):625-34. PubMed ID: 16949099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Grey and white matter differences in brain energy metabolism in first episode schizophrenia: 31P-MRS chemical shift imaging at 4 Tesla.
    Jensen JE; Miller J; Williamson PC; Neufeld RW; Menon RS; Malla A; Manchanda R; Schaefer B; Densmore M; Drost DJ
    Psychiatry Res; 2006 Mar; 146(2):127-35. PubMed ID: 16497488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Asymmetry of temporal lobe phosphorous metabolism in schizophrenia: a 31phosphorous magnetic resonance spectroscopic imaging study.
    Deicken RF; Calabrese G; Merrin EL; Vinogradov S; Fein G; Weiner MW
    Biol Psychiatry; 1995 Sep; 38(5):279-86. PubMed ID: 7495921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1H MRSI evidence of metabolic abnormalities in childhood-onset schizophrenia.
    O'Neill J; Levitt J; Caplan R; Asarnow R; McCracken JT; Toga AW; Alger JR
    Neuroimage; 2004 Apr; 21(4):1781-9. PubMed ID: 15050598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between cortical metabolite levels and clinical manifestations of migrainous aura: an MR-spectroscopy study.
    Schulz UG; Blamire AM; Corkill RG; Davies P; Styles P; Rothwell PM
    Brain; 2007 Dec; 130(Pt 12):3102-10. PubMed ID: 17956910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic alterations in medication-free patients with bipolar disorder: a 3T CSF-corrected magnetic resonance spectroscopic imaging study.
    Port JD; Unal SS; Mrazek DA; Marcus SM
    Psychiatry Res; 2008 Feb; 162(2):113-21. PubMed ID: 18164911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 31phosphorus magnetic resonance spectroscopy of the frontal and parietal lobes in chronic schizophrenia.
    Deicken RF; Calabrese G; Merrin EL; Meyerhoff DJ; Dillon WP; Weiner MW; Fein G
    Biol Psychiatry; 1994 Oct; 36(8):503-10. PubMed ID: 7827212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative in vivo 31P magnetic resonance spectroscopy of Alzheimer disease.
    Gonzalez RG; Guimaraes AR; Moore GJ; Crawley A; Cupples LA; Growdon JH
    Alzheimer Dis Assoc Disord; 1996; 10(1):46-52. PubMed ID: 8919496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 31Phosphorus magnetic resonance spectroscopy of the temporal lobes in schizophrenia.
    Calabrese G; Deicken RF; Fein G; Merrin EL; Schoenfeld F; Weiner MW
    Biol Psychiatry; 1992 Jul; 32(1):26-32. PubMed ID: 1391294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 31P-MRS demonstrates a reduction in high-energy phosphates in the occipital lobe of migraine without aura patients.
    Reyngoudt H; Paemeleire K; Descamps B; De Deene Y; Achten E
    Cephalalgia; 2011 Sep; 31(12):1243-53. PubMed ID: 21289000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lateralized abnormality of high-energy phosphate and bilateral reduction of phosphomonoester measured by phosphorus-31 magnetic resonance spectroscopy of the frontal lobes in schizophrenia.
    Kato T; Shioiri T; Murashita J; Hamakawa H; Inubushi T; Takahashi S
    Psychiatry Res; 1995 Sep; 61(3):151-60. PubMed ID: 8545499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single voxel proton magnetic resonance spectroscopy in post-stroke depression.
    Glodzik-Sobanska L; Slowik A; McHugh P; Sobiecka B; Kozub J; Rich KE; Urbanik A; Szczudlik A
    Psychiatry Res; 2006 Dec; 148(2-3):111-20. PubMed ID: 17088051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measuring mania metabolites: a longitudinal proton spectroscopy study of hypomania.
    Malhi GS; Ivanovski B; Wen W; Lagopoulos J; Moss K; Sachdev P
    Acta Psychiatr Scand Suppl; 2007; (434):57-66. PubMed ID: 17688464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphorus magnetic resonance spectroscopic imaging in patients with frontal lobe epilepsy.
    Garcia PA; Laxer KD; van der Grond J; Hugg JW; Matson GB; Weiner MW
    Ann Neurol; 1994 Feb; 35(2):217-21. PubMed ID: 8109902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic mapping using 2D 31P-MR spectroscopy reveals frontal and thalamic metabolic abnormalities in schizophrenia.
    Smesny S; Rosburg T; Nenadic I; Fenk KP; Kunstmann S; Rzanny R; Volz HP; Sauer H
    Neuroimage; 2007 Apr; 35(2):729-37. PubMed ID: 17276699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [31P-MR spectroscopy of the brain in patients with anorexia nervosa: characteristic differences in the spectra between patients and healthy control subjects].
    Rzanny R; Freesmeyer D; Reichenbach JR; Mentzel HJ; Pfleiderer SO; Klemm S; Gerhard UJ; Blanz B; Kaiser WA
    Rofo; 2003 Jan; 175(1):75-82. PubMed ID: 12525985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypofrontality in panic disorder and major depressive disorder assessed by multi-channel near-infrared spectroscopy.
    Ohta H; Yamagata B; Tomioka H; Takahashi T; Yano M; Nakagome K; Mimura M
    Depress Anxiety; 2008; 25(12):1053-9. PubMed ID: 18833572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.